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Objective:Giant cell arteritis (GCA) is commonly known for its clinical presentation of temporal arteritis. However, GCA
affects large arteries, predominantly the aorta and its proximal branches, in up to 75% of cases. We describe the clinical
presentation and diagnostic test results of patients with large-vessel GCA.
Methods: Case description of 11 patients with large-vessel GCA diagnosed consecutively in our hospital.
Results: The clinical presentation of large-vessel GCA is highly variable, from systemic inflammation to aortic rupture.
Imaging shows variable abnormalities, but 18-fluorodeoxyglucose positron-emission-tomography (18-FDG PET) seems
to be a sensitive and reasonably specific diagnostic test for large-vessel GCA.
Conclusion: Large-vessel GCA is a clinically heterogeneous condition. 18-FDG PET should be considered in the
diagnostic work-up of suspected cases. Since this disorder has a high complication rate, and is responsive to treatment
with corticosteroids, a high level of clinical suspicion is warranted. (J Vasc Surg 2008;48:1025-31.)Giant cell arteritis (GCA) affects large- and medium-
sized vessels, and is best known for its manifestations in the
extracranial branches of the carotid artery. Its frequent
localization in the superficial temporal artery is the basis for
its common name “temporal arteritis.” Classic temporal
arteritis may cause headache (70%), jaw claudication (50%)
and, as its most feared complication, blindness.1-3 Systemic
manifestations of GCA can include fever, malaise, or weight
loss. There is a close association with polymyalgia rheu-
matica (PMR). These conditions often coexist and it has
been suggested that they are part of the same disease
spectrum. Of patients with temporal arteritis, 50% have
complaints compatible with PMR. In patients with PMR,
15% have temporal arteritis.4,5
Involvement of the aorta and its proximal branches in
GCA was described more than 35 years ago6 but is still
relatively unknown to many clinicians. The literature sug-
gests that clinically manifested aortic disease occurs in 10%
to 15% of GCA patients, about one third of whom present
with aortic dissection or rupture, which most commonly
affect the proximal thoracic aorta.7-9 Any type of clinically
manifested large artery (aorta and proximal branches) com-
plication has been reported to occur in up to 27% of
patients with GCA.10
In this paper, we present a case series of patients with
GCA with proven or probable large artery involvement.
Our purpose is to describe the heterogeneity in clinical
presentation (Table I), the potential diagnostic value of
positron emission tomography (PET), and to illustrate
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doi:10.1016/j.jvs.2008.04.054that, in some patients, the diagnosis needs to be established
on clinical grounds and imaging study results, because final
histopathologic confirmation is not always possible.
CASES
Patient 1 is a 63-year-old woman. In 1999 she was
seen in another hospital because of lower back pain and
weight loss, a raised erythrocyte sedimentation rate (ESR;
Table II) and anemia (hemoglobin, 6.1 mmol/L). On an
abdominal computed tomography (CT) scan, infrarenal
aortic wall thickening was seen. She was operated on and an
aortic prosthesis was placed. No histologic examination of
the thickened aortic wall was performed. In the following
years, her ESR was persistently elevated, and she continued
to complain of general malaise and fatigue. Her persistent
anaemia required multiple blood transfusions. In 2001, a
CT scan of the thorax (Fig 1) revealed aneurysmatic wid-
ening of the thoracic aorta, with marked aortic wall thick-
ening. The ESR at that time was 100 mm/h. An 18-
fluorodeoxyglucose (FDG) PET showed enhanced FDG
uptake (Fig 1) of the ascending thoracic aorta. These
findings raised suspicion of GCA, for which corticosteroid
treatment was started, with an immediate complete remis-
sion of complaints and laboratory abnormalities. As further
support for the diagnosis, biopsy of the normal appearing
temporal artery was performed and showed abnormal wall
architecture with marked destruction of the internal lamina
elastica, compatible with temporal arteritis, which by that
time had become inactive after steroid treatment. Later
during her clinical course, she was operated on for severe
aortic regurgitation, for which a Bentall procedure (re-
placement of aortic valve and ascending aortic graft place-
ment) was performed. Histopathologic examination of the
aortic wall biopsies obtained during surgery showed a pic-
ture similar to that of the earlier temporal artery biopsy.
Patient 2 is a 61-year-old female. She was admitted
because of a symptomatic 5-cm thoracoabdominal aortic
aneurysm. Eighteen months earlier she was treated with
1025
deoxy
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mal muscle weakness, general malaise, and high ESR) for a
period of 14 months. Three months before presentation
she had complained of pain in the epigastric region. She was
operated on and an aortic prosthesis was placed. His-
topathologic examination of the aortic wall showed lym-
Table I. Clinical characteristics of the 11 cases
Patient Gender Age (y)
1 Female 64 Weigh
2 Female 60 Epigas
3 Female 51 Spiking
4 Female 62 Ruptu
5 Female 73 Arm an
6 Female 76 Malais
7 Female 72 Jaw cla
8 Female 56 Interm
9 Female 53 Aortic
10 Female 76 Malais
11 Female 57 Arm cl
PMR, Polymyalgia rheumatica.
Table II. Diagnostic characteristics of the 11 cases
Patient Diagnosis based on
1 Temporal artery biopsy
2 Aortic wall biopsy
3 PET imaging
4 CT angiography and PET imaging
5 PET imaging
6 Temporal artery biopsy
7 Temporal artery biopsy
8 PET imaging
9 Clinical presentation only
10 Temporal artery biopsy and PET imaging
11 PET imaging
ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein; FDG, fluoro
Fig 1. Patient 1. Transverse CT scan of the thorax (left)
and an 18-FDG PET scan (right) with intense 18-FDG u
heart (green arrow) is physiologic.phocytic infiltrates and giant cells, compatible with GCA. APET was performed postoperatively and showed enhanced
18-FDG uptake in only the region of the aortic endopros-
thesis. She was treated with corticosteroids and her clinical
course remained uneventful.
Patient 3 is a 51-year-old female. She was admitted
because of a 6-week period of spiking fever, night sweats,
Clinical presentation Time to diagnosis
, lower back pain 6 y
nd flank pain 3 mo
r, weight loss, sweating 2 mo
dominal aorta aneurysm 4 wk
claudication 5 mo
ximal muscle weakness, weight loss 4 mo
tion, fatigue 8 mo
t claudication, PMR 1 y
ction 6 y after diagnosis of PMR 6 y
ximal muscle weakness 2 mo
ation, malaise 1 y
ESR (mm/h) CRP (mg/L) 18-FDG PET
106 Positive
4 14 Positive
115 141 Positive
60 36 Positive
22 29 Positive
84 80 Not performed
70 55 Positive
14 9 Positive
10 Not performed
128 73 Positive
80 63 Positive
glucose; PET, positron emission tomography; CT, computed tomography.
ing thickening of the ascending aortic wall (white arrow)
in the ascending aorta (white arrow). The uptake in thet loss
tric a
feve
red ab
d leg
e, pro
udica
itten
disse
e, pro
audicshow
ptakeand weight loss, for which no cause had been identified in
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on for aortic valve stenosis after acute rheumatic fever
during childhood. Four months prior to the onset of com-
plaints, a pacemaker was placed because of a total atrioven-
tricular conduction block. Transthoracic echocardiography
at this time revealed no abnormalities. Physical examination
was unremarkable besides a fever of 38.5° C. Her ESR was
markedly elevated (Table II). Endocarditis of the aortic
prosthetic valve or an infected pacemaker lead was sus-
pected; however, blood cultures remained negative. Trans-
esophageal echocardiography (TEE) showed a soft tissue
mass surrounding the aortic valve ring. Abdominal ultra-
sonography suggested aortic wall thickening. A subsequent
abdominal CT scan revealed segmental aortic wall thicken-
ing with encasement of the left renal artery), and an 18-
FDG PET showed enhanced uptake in the prosthetic aortic
valve area, as well as in a small area of the abdominal aorta,
and in the right carotid artery region (Fig 2). Ultrasound
examination of the carotid arteries revealed a90% stenosis
on the right side, with marked arterial wall thickening. A
less pronounced stenosis (50%) was found in the left
carotid artery. Because of negative blood cultures, the lack
of response to antibiotics, the findings on CT, PET, and
TEE, GCAwas suspected. A 1.2-cm biopsy of the temporal
artery was normal. Nonetheless, treatment with corticoste-
roids was started and was followed by rapid disappearance
of her fever and an acute phase response. Her further
clinical course remained uneventful.
Patient 4 is a 62-year-old female who presented with
acute abdominal pain. Ultrasonography revealed rupture of
a 4.4-cm abdominal aortic aneurysm, which was confirmed
by thoracoabdominal CT angiography. She underwent suc-
cessful emergency surgery, during which an infrarenal aortic
vascular prosthesis was placed. Histopathologic examination
Fig 2. Patient 3. Transverse CT scan of the abdomen (
(white arrow). A left renal artery stenosis is also seen (gree
18-FDG uptake in the abdominal aorta (green arrow) an
uptake in the heart (white arrow) is normal. The upper
uptake in the right carotid artery (white arrow).of the aneurysm wall revealed nonspecific inflammation. Fivedays after surgery, new onset thoracic pain occurred. A CT
scan revealed aneurysmatic dilatation of the ascending
aorta and type B aortic dissection, which was not present
on the first CT scan. The dissection was treated conserva-
tively. Because of the acute phase reaction (Table II), GCA
was considered. A 1-cm biopsy of the temporal artery was
normal. Subsequently, an 18-FDG PET was performed,
which revealed increased FDG uptake not only in the areas
of dissection and surgery but also in the arcus aortae. Our
clinical diagnosis was probable GCA. After treatment with
corticosteroids was initiated, the acute phase reaction nor-
malized. Her further clinical course was uneventful.
Patient 5 is a 73-year-old female who presented with
bilateral claudication of the upper extremities since 5
months. A year before she had an episode of leg claudica-
tion, which improved with a graded exercise program. On
physical examination, pulsations of the upper extremities
were absent. The temporal arteries were normal. A right-
sided subclavian murmur was noted. Pulsations of the
lower extremities were normal. Blood tests revealed a mild
acute phase response (Table II). A 1-cm biopsy of the
temporal artery was normal. A CT scan (Fig 3) showed wall
thickening and stenosis of predominantly the left subcla-
vian artery, and an 18-FDG PET (Fig 3) showed high
uptake in the arcus aortae, descending aorta, brachioce-
phalic trunk, and the left carotid artery. Because of these
findings, she was diagnosed with probable GCA and
treated with corticosteroids. Her complaints disappeared
within 2 months of treatment.
Patient 6 is a 76-year-old female. She complained of
general malaise, weight loss, headache, and proximal mus-
cle weakness of 4 months’ duration. Because of the weight
loss, a CT scan of the abdomen was performed, which
revealed a type B aortic dissection. Because of the aortic
ith remarkable thickening of the abdominal aortic wall
ow). On the right is an 18-FDG PET scan showing high
branches of the arcus aorta (black arrow). The 18-FDG
side is another frontal plane showing intense 18-FDGleft) w
n arr
d the
rightdissection, combined with themarked acute phase response
row).
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was performed despite normal findings on physical exami-
nation of the temporal arteries. Histopathology of this
biopsy revealed GCA (arterial wall inflammation with giant
cells and histiocytes, and marked fragmentation of the
lamina elastica). The dissection was treated conservatively.
She was treated with corticosteroids, which was followed by
normalization of the laboratory tests and an uneventful
further clinical course.
Patient 7 is a 73-year-old female. She complained of
fatigue, jaw claudication, and general malaise of 8 months’
duration. On physical examination, her blood pressure on
the right side was lower (140/80 mmHg) than on the left
side (160/80mmHg). Because of her clinical presentation
and the acute phase response (Table II), temporal arteritis
was suspected. Histopathologic examination of a 2.4-cm
temporal artery biopsy showed giant cells, histiocytes, and
destruction of the lamina elastica, confirming the diagnosis.
An 18-FDG PET scan and CT scan were performed to
evaluate the cause of the blood pressure difference. The
PET scan showed enhanced uptake in the arcus aortae,
both subclavian arteries, and axillary arteries. A CT angiog-
raphy revealed thickening of descending aortic wall. Both
findings were suggestive for aortitis. She was treated with
corticosteroids, with an excellent clinical and biochemical
response.
Patient 8 is a 56-year-old female. She complained of
progressive leg claudication. One year earlier, she was
treated with corticosteroids because of PMR. Her com-
plaints at that time consisted of pain in both shoulders and
general malaise. The response to corticosteroids was excel-
lent. At the time of presentation, she used only 1 mg of
prednisone per day. On physical examination, a systolic
murmur over the left subclavian artery was noted. All
peripheral arterial pulsations were diminished or absent.
On laboratory examination, a mildly elevated acute phase
response was seen (Table II). An 18-FDG PET (Fig 4)
showed enhanced uptake in the abdominal aorta from the
Fig 3. Patient 5. Transverse CT scan of the thorax (left
remarkable thickening of the artery wall. On the right
ascending aorta (black arrow) and its branches (white arrenal arteries downwards, including the femoral arteries.Magnetic resonance angiography revealed occlusion of the
proximal right and left superficial femoral artery. Large-
vessel GCA was suspected. Following treatment with cor-
ticosteroids, her leg claudication complaints improved dra-
matically. Although the PET findings could also be
compatible with atherosclerosis, her medical history and
excellent response to corticosteroids support the diagnosis
of GCA. A follow-up 18-FDG PET scan performed 1 year
later was normal.
Patient 9 is 54-year-old female. She was admitted
stenosis of the left subclavian artery (white arrow) with
is an 18-FDG PET scan showing high uptake in the
Fig 4. Patient 8. An 18-FDG PET scan with high uptake in both
femoral arteries (white arrows).) with
sidebecause of thoracic pain with progressive dilatation of a
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placed. The dissection had been discovered 6 months ear-
lier, at which time she was treated conservatively with
antihypertensive medication. Eight years earlier, she was
diagnosed with temporal arteritis in another hospital. Since
that time treatment with corticosteroids could never be
stopped completely because of recurrent complaints. At the
time the endoprosthesis was placed, she used 1 mg pred-
nisolone per day. Immediately after placement of the endo-
prosthesis, she had a normal ESR (Table II). Nonetheless,
she was treated postoperatively with high-dose pred-
nisolone. In conclusion, this patient experienced an aortic
dissection 6 years after temporal arteritis was diagnosed.
Patient 10 is a 77-year-old female. She complained of
malaise, myalgia of the upper extremities, and occasional
headache of a few months’ duration. Physical examination
revealed no abnormalities, particularly no abnormal appear-
ance or palpation of the temporal arteries. Because of these
complaints and an elevated ESR (Table II), an 18-FDG
PET was performed, showing high uptake in the arcus
aortae, both subclavian and carotid arteries, and the ab-
dominal aorta. Again, GCA was suspected and a 0.5-cm
temporal artery biopsy showed giant cells, histiocytes and
destruction of the lamina elastica, thus confirming the
clinical diagnosis. High-dose corticosteroids were started,
followed by complete resolution of her complaints and
acute phase response within a few days.
Patient 11 is a 58-year-old female. She was referred
because of arm claudication, malaise, and fatigue of 1 year’s
duration. One year earlier, she was diagnosed with PMR in
another hospital. Treatment with corticosteroids resulted
in slight improvement of her complaints, but her elevated
acute phase response persisted. She was referred to our
hospital. A 2-cm temporal artery biopsy was normal. Phys-
ical examination revealed no palpable pulse of the brachial
arteries. A CT angiography showed occlusion of the right
axillary artery and irregularities of the right subclavian
artery. Large-vessel GCA was suspected because of these
findings and the persistent acute phase response. An 18-
FDG PET showed high uptake in most large thoracic
vessels, compatible with arteritis. She was treated with
high-dose corticosteroids with an excellent clinical re-
sponse.
DISCUSSION
We describe 11 patients in whom large-vessel GCA was
either biopsy-proven or diagnosed on the basis of a high
level of clinical suspicion. Our case descriptions illustrate a
number of important aspects of large-vessel GCA. First, the
heterogeneity of clinical presentation is large (Table I).
Second, 18-FDG PET appears to be a useful diagnostic test
for large-vessel GCA. Finally, definitive (histopathologic)
confirmation is often difficult to obtain, because temporal
artery biopsy may be normal, and aortic and other large-
vessel biopsies are often not available, unless there is a
vascular calamity requiring aortic surgery.
In our 11 patients with large-vessel GCA, the clinical
heterogeneity was remarkable. The clinical presentationvaried from symptoms highly suggestive of classic temporal
arteritis with subclinical aortitis (patient 7), to symptoms of
weight loss and/or fever with elevated inflammatory pa-
rameters (patients 1, 3, 6, and 10), symptoms of arterial
occlusive disease (patients 5, 8, and 11), and aortic aneu-
rysm or dissection (patients 2, 4, and 9). The literature on
large-vessel GCA suggests that the most common manifes-
tations, apart from temporal artery symptoms, are systemic
inflammation and acutely symptomatic aortic aneurysm or
dissection.7,8 The risk of thoracic aneurysm formation in
patients with temporal arteritis is increased by approxi-
mately 17-fold, and the risk of abdominal aortic aneurysm
by about 2- to 3-fold.8 Importantly, involvement of the
aorta or its proximal branches in GCA initially may be
asymptomatic or associated with nonspecific complaints.
However, some of the other manifestations we have de-
scribed have also been reported earlier, including peripheral
arterial occlusive disease.11
All patients were female and over the age of 50 years,
which is compatible with current knowledge of the epide-
miology of GCA.3,12-14 As for the laboratory abnormalities
in large-vessel GCA, we found that erythrocyte sedimenta-
tion rate and C-reactive protein were usually, but not
universally (patients 2 and 9), markedly increased. The
suboptimal sensitivity of these inflammation markers was
previously documented for temporal arteritis15,16 and ap-
parently applies also to large-vessel GCA, even though one
would imagine the more widespread vascular involvement
to be reflected in universally elevated systemic inflamma-
tion markers.
The diagnosis of GCA can be established with certainty
only by histopathologic examination of an arterial wall
biopsy. As is true for the exact prevalence of large-vessel
involvement in temporal arteritis and PMR, the prevalence
of temporal arteritis in large-vessel GCA is not well studied.
Histopathologic examination of a temporal artery biopsy
was performed in seven patients, and only three of them
showed evidence of GCA. Temporal artery biopsy is re-
garded by many to be the gold standard for diagnosing
GCA. However, suboptimal sensitivity of temporal artery
biopsy has been noted even in classic temporal arteritis and
is ascribed to the segmental nature of the disease.17,18 For
this reasons, temporal artery biopsies of at least 3, prefera-
bly even 5 cm in length are advised. Alternatively, the use of
high-frequency ultrasonographic imaging of the temporal
artery to guide biopsy is worth considering.19 Even with
large or ultrasound-guided biopsies, however, a contralat-
eral biopsy may be required to confirm the diagnosis.3,20
Thus, one explanation for the suboptimal sensitivity is
sampling error, which might have been lower if 5-cm
biopsies, ultrasound-guided biopsies, and/or contralateral
temporal artery biopsies had been taken in all patients.
However, the alternative explanation for the negative tem-
poral artery biopsy findings is that large-vessel GCA may
not be associated with temporal artery abnormalities at all
in a significant proportion of patients. This explanation
would have important implications for the appropriate use
of terms for this disease spectrum. Using the term “tempo-
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the temporal artery is universally involved. We suggest that
this term is best avoided whenever a differential diagnosis of
systemic inflammation in an elderly person is made. The use
of this term may limit further clinical attention strictly to
the temporal arteries, whereas use of the term “giant cell
arteritis” would appropriately draw attention to all poten-
tial sites of GCA involvement, including large arteries. We
thus feel that the American College of Rheumatology
(ACR) criteria for classifying GCAmay cause underdiagno-
sis of large-vessel GCA, because headache, temporal artery
abnormalities on physical examination, and a positive tem-
poral artery biopsy are the main classification criteria pro-
posed by the ACR.21 In our opinion these criteria should
either be explicitly reserved for classification of temporal
arteritis rather than GCA or should be expanded to include
signs and symptoms of large-vessel GCA.
So, when should large-vessel GCA be suspected and
what should be the diagnostic workup? On the basis of the
clinical heterogeneity, large-vessel GCA should be consid-
ered in a variety of clinical conditions, which at least include
systemic inflammatory disease with no alternative cause,
and aortic or large-vessel aneurysmatic or obstructive dis-
ease with markedly elevated laboratory signs of systemic
inflammation. Although temporal artery biopsy is a reason-
able next step in the diagnostic process, our case series as
well as recent literature suggests that 18-FDG PET is both
a sensitive and a specific test for large-vessel GCA. An
18-FDG PET is a noninvasive imaging modality. Deoxy-
glucose is labeled with the positron-emitting radionuclide
18-fluoride and is administered to patients after fasting.
The 18F-FDG follows the samemetabolic route as glucose;
thus, it is taken up predominantly by metabolically active
cells, such as cancer and inflammatory cells.22 The intro-
duction of the 18-FDG PET has been a major break-
through in the diagnosis of large-vessel GCA. In a study of
69 patients with confirmed or suspected temporal arteritis
or PMR, increased 18-FDG uptake in the aorta or its
proximal branches suggesting vasculitis was noted in 76% of
those with confirmed disease, in 23% of those with sus-
pected disease, and in only 2% of healthy controls.12
Hence, this study confirmed that in both temporal arteritis
and GCA, subclinical large-vessel involvement is much
more common than clinically manifested involvement.
Other studies addressing the value of 18-FDG PET in
large-vessel GCA showed that increased uptake was most
prevalent in patients with predominantly systemic com-
plaints.12,23 Also in patients with GCA with a negative
temporal artery biopsy, 18-FDG PET was shown to be
useful.12,23,24 In nine of our patients, the diagnosis large-
vessel GCA was supported by a positive 18-FDG PET, thus
supporting an important role for 18-FDG PET in the
diagnostic workup.
The differential diagnosis of enhanced uptake of 18-
FDG in large vessels includes extensive atherosclerosis. If
atherosclerosis is not evident clinically or by other imaging
modalities, the differential diagnosis may be difficult, al-
though atherosclerosis generally results in a more patchy,scattered pattern and less intense uptake of 18-FDG than
does vasculitis.22,25 In this context, liver uptake of 18-FDG
can be used to help quantify the relative intensity of vascular
uptake.22 Experience in large-vessel PET is required to
differentiate vasculitis from atherosclerosis. Other condi-
tions mimicking large-vessel GCA on 18-FDG PET in-
clude other forms of immune-mediated vasculitis such as
Takayasu disease, which is similar to large-vessel GCA but
occursmore often in youngwomen andhas a stronger genetic
susceptibility profile,22 infectious vasculitis such as syphilitic
aortitis,26 and retroperitoneal fibrosis (“peri-aortitis”).25 Al-
though we found little evidence in the literature, our clin-
ical experience is that vascular prostheses show up on an
18-FDG PET for many years after surgery.
When an 18-FDG PET is negative or unavailable, there
may be a diagnostic dilemma in patients who have large-
vessel disease that is morphologically and clinically compat-
ible with GCA and a normal temporal artery biopsy. Large-
vessel biopsy, the gold standard, will be unavailable in most
cases; thus, the diagnosis needs to be made on clinical
grounds.
As for treatment of large-vessel GCA, corticosteroids
are central.3 In patients who show an incomplete response
to corticosteroids or who require large doses for prolonged
periods, additional immunosuppressants have been tried.
Of these, methotrexate appears to be effective.3 Preliminary
evidence suggests that increased uptake of 18-FDG nor-
malizes after immune suppression27; therefore, further
studies should be done to determine if 18-FDG PET is a
suitable technique to monitor disease activity or progres-
sion. If surgery is required, for example to restore aortic
valve function, to treat symptomatic aneurysms, or to re-
store patency of aortic branches, there is a paucity of
literature on which specific problems are encountered or
whether specific surgical procedures are required.
In conclusion, the clinical presentation of large-vessel
GCA is variable; thus, the diagnosis should be considered in
patients presenting with systemic inflammation or large-
vessel disease associated with laboratory signs of inflamma-
tion. Temporal artery biopsy is specific for GCA, but false-
negative test results are common. If biopsy of the affected
arterial wall is not available, 18-FDG PET appears to be the
diagnostic test of choice in suspected large-vessel GCA.
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